Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,137 public trials 1,865 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, not recruiting

A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

NCT04440735

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Moores Cancer Center, UCSD La Jolla, California, United States
  • University of Colorado Hospital, Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Active, not recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details
Active, not recruiting

Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)

NCT05712902

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital，Capital Medical University Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View all 33 locations
View Trial Details
Active, not recruiting

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

NCT06008353

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • Oncologia D'Or Unidade Esperança Pernambuco Recife, Pernambuco, Brazil
  • Instituto D'Or de Pesquisa e Ensino RJ Rio de Janeiro, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
View Trial Details
Active, not recruiting

Tumor-specific T Cells in Lung Cancer

NCT02515760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Division of Thoracic Surgery, Technical University of Munich, Munich, Germany Munich, Germany
View Trial Details
Active, not recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT03425643

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0028) Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. ( Site 0050) Goodyear, Arizona, United States
  • University of Arizona Cancer Center - Dignity Health ( Site 0062) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0012) Tucson, Arizona, United States
View all 227 locations
View Trial Details

Related conditions